Inhibition of DDR1-BCR signalling by nilotinib as a new therapeutic strategy for metastatic colorectal cancer.
about
Inhibition of DDR1-BCR signalling by nilotinib as a new therapeutic strategy for metastatic colorectal cancer.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Inhibition of DDR1-BCR signall ...... metastatic colorectal cancer.
@en
Inhibition of DDR1-BCR signall ...... metastatic colorectal cancer.
@nl
type
label
Inhibition of DDR1-BCR signall ...... metastatic colorectal cancer.
@en
Inhibition of DDR1-BCR signall ...... metastatic colorectal cancer.
@nl
prefLabel
Inhibition of DDR1-BCR signall ...... metastatic colorectal cancer.
@en
Inhibition of DDR1-BCR signall ...... metastatic colorectal cancer.
@nl
P2093
P2860
P50
P356
P1476
Inhibition of DDR1-BCR signall ...... metastatic colorectal cancer.
@en
P2093
Alain R Thierry
Amaëlle Otandault
Bruno Robert
Caroline Mollevi
Cédric Leroy
Debora Bonenfant
Fanny Grillet
Jordy Le Guet
Lucile Canterel-Thouennon
Marie Lafitte
P2860
P356
10.15252/EMMM.201707918
P577
2018-04-01T00:00:00Z